GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and largescale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industryleading exome and genome testing and interpretation services, fueled by the world’s largest, rare disease data sets. For more information, please visit www.genedx.com.
EDUCATION, EXPERIENCE, AND SKILLS:
Wella Company
Xplor
MDA Edge
MasterBrand Cabinets LLC
Wella Company